TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Input di momentum (manager comparabili):
ampiezza dei detentori -8.7% ·
flusso azionario -0.7% ·
nuove posizioni nette -9.5%
— formula
Distribuzione diffusa — azioni in calo e minor numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q3 2024
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.61M | $131.45B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.97M | +10.6% | $6.79B | 0.8% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.97M | +10.6% | $6.79B | 0.8% | ▲ Add | 2 | SEC ↗ |
| 3 | Capital World Investors ✦ | 9.33M | -2.0% | $5.77B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passivo) | 7.66M | +1.7% | $4.72B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passivo) | 7.66M | +1.7% | $4.72B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passivo) | 5.59M | +0.4% | $3.46B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 2.64M | +2.5% | $1.63B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 8 | PRIMECAP Management ✦ | 2.57M | -3.5% | $1.59B | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 397.23K | -7.2% | $245.71M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 357.72K | +1.6% | $221.28M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 337.85K | +67.9% | $208.98M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 337.85K | +67.9% | $208.98M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 32 | Arrowstreet Capital ✦ | 206.32K | +588.9% | $127.63M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 166.19K | -83.1% | $102.80M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 166.19K | -83.1% | $102.80M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 35 | Millennium Management ✦ | 122.48K | -78.3% | $75.76M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 48.95K | -79.2% | $30.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Markel Group ✦ | 35.40K | +20.4% | $21.90M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 38 | Dodge & Cox ✦ | 26.77K | -0.1% | $16.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Gotham Asset Management ✦ | 23.41K | +10.0% | $14.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 40 | GAMCO Investors ✦ | 4.28K | -0.2% | $2.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Nessun nuovo acquirente tracciato questo trimestre. |
Uscito
| Point72 Asset Management | $186.10M | era 0.6% |
| Bridgewater Associates | $18.65M | era 0.1% |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 1 detentori, 24.30K azioni, $11,944 dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Acquisti sul mercato aperto (P)
Nessun acquisto insider sul mercato aperto nella nostra finestra di copertura.
Vendite sul mercato aperto (S)
Officer, Director · 321 az. · $201,941
Officer, Director · 3.01K az. · $1.89M
Officer, Director · 1.79K az. · $1.12M
Officer, Director · 2.15K az. · $1.35M
Officer, Director · 2.73K az. · $1.71M
Officer, Director · 560 az. · $354,446
Officer, Director · 80 az. · $50,719
Officer, Director · 1.31K az. · $824,745
Officer, Director · 2.60K az. · $1.64M
Officer, Director · 1.25K az. · $787,312
Assegnazioni, esercizi e ritenute fiscali non vengono mai conteggiati come acquisti o vendite in questa sede. Metodologia